Increased levels of monokine induced by interferon‐γ (Mig) in the vitreous of patients with diabetic retinopathy

Aim  To determine the intravitreous concentration of monokine induced by interferon‐γ (Mig) in patients with diabetic retinopathy (DR) and the relation between Mig and vascular endothelial growth factor (VEGF).

[1]  H. Yamashita,et al.  Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. , 2006, Ophthalmology.

[2]  M. R. Powers,et al.  Increased Expression of Chemokine KC, an Interleukin-8 Homologue, in a Model of Oxygen-Induced Retinopathy , 2005, Current eye research.

[3]  Ulrich Schraermeyer,et al.  A central role for inflammation in the pathogenesis of diabetic retinopathy , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  M. Iannettoni,et al.  The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis. , 2000, Human gene therapy.

[5]  R. Strieter,et al.  Interferon-induced protein 10 and interleukin 8. C-X-C chemokines present in proliferative diabetic retinopathy. , 1998, Archives of ophthalmology.

[6]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[7]  Armen B. Shanafelt,et al.  The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.

[8]  M. Serio,et al.  Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. , 2001, The Journal of clinical investigation.

[9]  Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.